Cost-Effectiveness of Cetuximab as First-Line Treatment for Metastatic Colorectal Cancer in the United States
May 1, 2014, 00:00
10.1016/j.jval.2014.03.500
https://www.valueinhealthjournal.com/article/S1098-3015(14)00551-8/fulltext
Title :
Cost-Effectiveness of Cetuximab as First-Line Treatment for Metastatic Colorectal Cancer in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00551-8&doi=10.1016/j.jval.2014.03.500
First page :
A86
Section Title :
Cancer
Open access? :
No
Section Order :
1552